BioIntelliSense
Golden, US · Delaware corporation · 83 employees on LinkedIn · 4 known investors
Find your way into BioIntelliSense
455 people in our graph share verified history with the BioIntelliSense team — schools, employers, funds. One of them is your warm intro.
Glen Andersonunlockedknows James Mault · together at University of Michigan (overlapped)
×3knows the team · via Qualcomm
×2knows the team · via University of Michigan
×5knows the team · via Duke University
knows the team · via Bose Corporation
BioIntelliSense develops scalable physiologic monitoring technology for continuous, proactive patient monitoring aimed at improving clinical outcomes and lowering the cost of care. Founded in 2019, the company builds medical monitoring solutions for healthcare providers and patients.
Founders & leadership
JM
James MaultinExecutive Chairman and FounderDr. Mault is a surgeon and health technology executive with over 35 years in healthcare IT and medical devices. He previously served as Chief Medical Officer at Qualcomm Life and founded HealthyCircles, a remote patient monitoring platform acquired by Qualcomm in 2013; earlier roles include medical director at Microsoft's Health Solutions Group and CEO of Microlife.
DW
David WanginCEO
RC
Ronald ChwangNamed on SEC filing
AM
Alan MeekerNamed on SEC filing
LL
Larry LeisureNamed on SEC filing
SH
Steve HessNamed on SEC filing
Board
CM
Conlan MaBoard director
XY
Xinyaun YuBoard director
Investors · 4
Reported raises · per SEC filings
Form D private placements$140.3M disclosed across 4 rounds · 2018–2025
▶$58.3MraisedJun 2026 · 14 investors · OtherRule 506(b)
▶$58.3MraisedJun 2026 · 14 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Conlan MaDirector
- David WangExecutive Officer, Director
- Xinyaun YuDirector
- James MaultExecutive Officer, Director
- Offering amount
- $58.4M
- Amount sold
- $58.3M
- First sale
- Dec 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$45MraisedSep 2022 · 16 investors · Other Health CareRule 506(b)
▶$45MraisedSep 2022 · 16 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- David WangExecutive Officer
- Alan MeekerDirector
- James R. MaultExecutive Officer, Director
- John DriscollDirector
- Lawrence LeisureDirector
- Steve HessDirector
- Offering amount
- $45M
- Amount sold
- $45M
- First sale
- Apr 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$25MraisedSep 2020 · 22 investors · Other Health CareRule 506(b)
▶$25MraisedSep 2020 · 22 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Steve HessDirector
- Alan MeekerDirector
- Larry LeisureDirector
- Ronald ChwangDirector
- James MaultExecutive Officer, Director
- Offering amount
- $25M
- Amount sold
- $25M
- First sale
- Dec 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$12MraisedSep 2020 · 11 investors · Other Health CareRule 506(b)
▶$12MraisedSep 2020 · 11 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- James MaultExecutive Officer, Director
- Ronald ChwangDirector
- Alan MeekerDirector
- Larry LeisureDirector
- Steve HessDirector
- Offering amount
- $12M
- Amount sold
- $12M
- First sale
- Aug 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 6
by search overlap
Rf Surgical34 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
LifeSignals33 shared keywordsLifeSignals develops silicon-based biosensor platforms and wearable monitoring solutions that enable clinical-grade health measurement outside traditional healthcare settings. The company targets widespread access to hospital-quality biomedical monitoring for individuals regardless of geographic proximity to medical facilities or economic status.
Biotricity23 shared keywordsBiotricity develops FDA-cleared wearable cardiac and remote patient monitoring devices that continuously capture ECG and vital-sign data for patients and deliver reports to physicians. Its products include the Bioflux/Biocore rhythm monitors and Biokit for clinics, plus consumer-facing Bioheart and HeartSecure heart-monitoring offerings.
Biofourmis21 shared keywordsBiofourmis provides technology-enabled solutions and a platform for AI-driven in-home patient care, using wearable biosensors and remote monitoring to deliver and transition patients across levels of care. It serves healthcare providers and partners, aiming to reduce hospital readmissions and cost of care.
Bioworld21 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Biolinq17 shared keywordsBiolinq develops the Shine sensor, a needle-free glucose monitor that measures glucose along with physical activity and sleep in a single wearable device. It uses an on-device LED light system to signal glucose levels in real time and pairs with a mobile app that provides personalized health insights and trend tracking.
Companies competing with BioIntelliSense for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does BioIntelliSense do?
- BioIntelliSense develops scalable physiologic monitoring technology for continuous, proactive patient monitoring aimed at improving clinical outcomes and lowering the cost of care. Founded in 2019, the company builds medical monitoring solutions for healthcare providers and patients.
- Who founded BioIntelliSense?
- BioIntelliSense was founded by James Mault.
- Who are BioIntelliSense's investors?
- BioIntelliSense's investors include Bose Ventures, CU Healthcare Innovation Fund, Fresenius Medical Care Ventures, SkyPoint Ventures.
- How much funding has BioIntelliSense raised?
- BioIntelliSense has disclosed $140.3M raised across 4 rounds.
- Where is BioIntelliSense headquartered?
- BioIntelliSense is headquartered in Golden, US.